Diverse inflammatory diseases, infections and malignancies are associated with wasting
syndromes. In many of these conditions, the standards for diagnosis and treatment are …

Muscle wasting is a consequence of physiological changes or a pathology characterized by
increased catabolic activity that leads to progressive loss of skeletal muscle mass and …

Cancer cachexia is a multifactorial condition characterized by body weight loss that
negatively affects quality of life and survival of patients with cancer. Despite the clinical …

Solid tumor growth and metastasis require the interaction of tumor cells with the surrounding
tissue, leading to a view of tumors as tissue-level phenomena rather than exclusively cell …

Cancer cachexia (CC) is a multifactorial syndrome in patients with advanced cancer
characterized by weight loss via skeletal-muscle and adipose-tissue atrophy, catabolic …

Pathologic diabetic wound healing is caused by sequential and progressive deterioration of
hemostasis, inflammation, proliferation, and resolution/remodeling. Cellular senescence …

Accumulation of dysfunctional white adipose tissues increases risks for cardiometabolic
diseases in obesity. In addition to white, brown or brite adipose tissues are also present in …

Cachexia is a wasting syndrome characterized by the continuous loss of skeletal muscle
mass due to imbalance between protein synthesis and degradation, which is related with …

Cancer cachexia (CC), characterized by body weight loss and sarcopenia, contributes to
over 20% of all cancer-related death. Approximately 80% of pancreatic cancer (PC) patients …

Cachexia is a metabolic syndrome consisting of massive loss of muscle mass and function
that has a severe impact on the quality of life and survival of cancer patients. Up to 20% of …